These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 24064667)
21. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients. Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794 [TBL] [Abstract][Full Text] [Related]
22. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351 [TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651 [TBL] [Abstract][Full Text] [Related]
24. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. Gandhi R; Farez MF; Wang Y; Kozoriz D; Quintana FJ; Weiner HL J Immunol; 2010 May; 184(9):4620-4. PubMed ID: 20368276 [TBL] [Abstract][Full Text] [Related]
25. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells. Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375 [TBL] [Abstract][Full Text] [Related]
26. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210 [TBL] [Abstract][Full Text] [Related]
27. LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. Camisaschi C; Casati C; Rini F; Perego M; De Filippo A; Triebel F; Parmiani G; Belli F; Rivoltini L; Castelli C J Immunol; 2010 Jun; 184(11):6545-51. PubMed ID: 20421648 [TBL] [Abstract][Full Text] [Related]
28. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Gasparoto TH; de Souza Malaspina TS; Benevides L; de Melo EJ; Costa MR; Damante JH; Ikoma MR; Garlet GP; Cavassani KA; da Silva JS; Campanelli AP Cancer Immunol Immunother; 2010 Jun; 59(6):819-28. PubMed ID: 20012605 [TBL] [Abstract][Full Text] [Related]
29. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Gupta S; Joshi K; Wig JD; Arora SK Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902 [TBL] [Abstract][Full Text] [Related]
30. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis. Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018 [TBL] [Abstract][Full Text] [Related]
31. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment. Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495 [TBL] [Abstract][Full Text] [Related]
32. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas. Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144 [TBL] [Abstract][Full Text] [Related]
33. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28. Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735 [TBL] [Abstract][Full Text] [Related]
34. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs. Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V Front Immunol; 2021; 12():716559. PubMed ID: 34335631 [TBL] [Abstract][Full Text] [Related]
35. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer. Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391 [TBL] [Abstract][Full Text] [Related]
36. Low expressions of PD-L1 and CTLA-4 by induced CD4 Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334 [TBL] [Abstract][Full Text] [Related]
37. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma. Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096 [No Abstract] [Full Text] [Related]
38. Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells. Wang Q; Feng M; Yu T; Liu X; Zhang P Cell Immunol; 2014 Feb; 287(2):100-5. PubMed ID: 24487033 [TBL] [Abstract][Full Text] [Related]